Cellply appointed Alex Jones as Chief Executive Officer effective August 1, 2026.
Published
Signal category
People
Quote
“We're proud to announce that Alex Jones (PhD/CEO) has joined Cellply as Chief Executive Officer, effective August 1st, 2026.”
— Cellply team
Company
Cellply
Unravelling immune system function, one cell at a time
- Industry
- Biotechnology Research
- Location
- Bologna, IT
- Company size
- 28 employees
Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution.
Founded 2013